In the present study, our data suggests that at the earlier stages of the AD cascade (i.e., in patients with moderately positive Centiloid values), plasma p-tau217 reflects earlier stages of tau spread, when tau is still mainly limited to the temporal lobes. Here, MAPT is linked to Alzheimer disease.